Emil Lou, MD, PhD, FACP, FASCO, is a physician-scientist and Professor of Medicine with tenure in the Division of Hematology, Oncology, and Transplantation at the University of Minnesota Medical School and a member of the Masonic Cancer Center. He serves as Medical Director of the Clinical Trials Office (CTO) Solid Tumor Unit and leads the Emil Lou Lab, with additional faculty involvement in the Integrative Biology and Physiology graduate program. Clinically, Dr. Lou focuses on gastrointestinal oncology, neuroendocrine oncology, and neuro-oncology care for patients with central nervous system involvement of solid tumors, integrating systemic therapies and clinical trial options. His research interests center on gene-editing and immunotherapy strategies, tumor microenvironment biology and intercellular communication, and biomarker-driven understanding of treatment response and resistance. Dr. Lou has been recognized on the TIME100 Health list and has been honored as a Minnesota Monthly Top Doctor. He has held national leadership roles within ASCO, including scientific committee service, tumor biology track leadership, and chairing the ASCO Social Media Working Group, and has served in education leadership for NANETS. He earned his MD and PhD in Microbiology and Immunology from SUNY Upstate Medical University, completed an Internal Medicine residency at Duke University Medical Center, and pursued fellowship training at Memorial Sloan Kettering Cancer Center in medical oncology/hematology and at Duke University Medical Center in neuro-oncology.
Professor
Medical School
1998 – 2004
Residency
2004 – 2007
Fellowship
2007 – 2010